|
Cord Blood America, Inc. - Comparative Business Analysis Snapshot
Business Description
Cord Blood America, Inc.. The Group's principal activities are to collect, test, and process and cryogenically preserve umbilical cord blood, thereby allowing families to preserve cord blood at the birth of a child for potential use in future stem cell therapy. It operates in two segments namely Umbilical Cord Blood and Radio/TV Advertising. The Group provide a medical kit that contains all of the materials necessary for collecting the newborn's umbilical cord blood at birth and packaging the unit for transportation. The Group also provides Full-time physician and customers support, comprehensive testing, and cold blood preservation facilities to its customers. The Group operates throughout the United States.
Competitor Analysis
This analysis compares Cord Blood America, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
